Similar Natural Products in NPASS
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC325909 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
range |
Tanimoto Coefficient |
0-0.1 | 4558 |
0.1-0.2 | 21820 |
0.2-0.3 | 3326 |
0.3-0.4 | 862 |
0.4-0.5 | 270 |
0.5-0.6 | 45 |
0.6-0.7 | 6 |
0.7-0.8 | 1 |
0.8-0.85 | 0 |
0.85-0.9 | 0 |
0.9-0.95 | 1 |
0.95-1 | 0 |
  Similar Clinical/Approved Drugs
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC325909 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
range |
Tanimoto Coefficient |
0-0.1 | 615 |
0.1-0.2 | 6564 |
0.2-0.3 | 1336 |
0.3-0.4 | 432 |
0.4-0.5 | 134 |
0.5-0.6 | 51 |
0.6-0.7 | 17 |
0.7-0.8 | 4 |
0.8-0.85 | 0 |
0.85-0.9 | 0 |
0.9-0.95 | 7 |
0.95-1 | 1 |
Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9643 |
High Similarity |
NPD9060 |
Approved |
0.9286 |
High Similarity |
NPD110 |
Approved |
0.9286 |
High Similarity |
NPD8821 |
Approved |
0.9286 |
High Similarity |
NPD9262 |
Approved |
0.9286 |
High Similarity |
NPD8818 |
Approved |
0.9286 |
High Similarity |
NPD8817 |
Phase 3 |
0.9286 |
High Similarity |
NPD8820 |
Approved |
0.9286 |
High Similarity |
NPD8819 |
Approved |
0.7879 |
Intermediate Similarity |
NPD8556 |
Phase 3 |
0.7188 |
Intermediate Similarity |
NPD9058 |
Approved |
0.7188 |
Intermediate Similarity |
NPD9057 |
Approved |
0.7027 |
Intermediate Similarity |
NPD9043 |
Approved |
0.6857 |
Remote Similarity |
NPD8800 |
Approved |
0.6765 |
Remote Similarity |
NPD9237 |
Approved |
0.6765 |
Remote Similarity |
NPD9238 |
Approved |
0.6486 |
Remote Similarity |
NPD9042 |
Approved |
0.6486 |
Remote Similarity |
NPD9236 |
Approved |
0.6486 |
Remote Similarity |
NPD9235 |
Approved |
0.6286 |
Remote Similarity |
NPD8795 |
Approved |
0.6286 |
Remote Similarity |
NPD8796 |
Approved |
0.6286 |
Remote Similarity |
NPD8799 |
Approved |
0.619 |
Remote Similarity |
NPD9229 |
Approved |
0.6136 |
Remote Similarity |
NPD399 |
Approved |
0.6136 |
Remote Similarity |
NPD9463 |
Phase 3 |
0.6136 |
Remote Similarity |
NPD9462 |
Approved |
0.6136 |
Remote Similarity |
NPD398 |
Approved |
0.6136 |
Remote Similarity |
NPD400 |
Approved |
0.6 |
Remote Similarity |
NPD8613 |
Approved |
0.6 |
Remote Similarity |
NPD383 |
Approved |
0.5957 |
Remote Similarity |
NPD2693 |
Approved |
0.5957 |
Remote Similarity |
NPD2692 |
Approved |
0.5854 |
Remote Similarity |
NPD335 |
Approved |
0.5854 |
Remote Similarity |
NPD331 |
Approved |
0.5745 |
Remote Similarity |
NPD9225 |
Phase 3 |
0.5745 |
Remote Similarity |
NPD9226 |
Approved |
0.5714 |
Remote Similarity |
NPD8816 |
Approved |
0.5714 |
Remote Similarity |
NPD334 |
Phase 3 |
0.5714 |
Remote Similarity |
NPD1433 |
Approved |
0.5714 |
Remote Similarity |
NPD9228 |
Approved |
0.5714 |
Remote Similarity |
NPD9457 |
Approved |
0.5714 |
Remote Similarity |
NPD1437 |
Approved |
0.5714 |
Remote Similarity |
NPD9456 |
Approved |
0.5652
|
Remote Similarity |
NPD8583 |
Phase 2 |